Innate Pharma (IPHA) Return on Assets [ROA] (2021 - 2026)
Innate Pharma (IPHA) recorded Return on Assets [ROA] of -277.10% in the quarter ended Jun 30, 2026, down 177.19 percentage points from -99.91% a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Innate Pharma reported Return on Assets [ROA] of -58.16%, down 24.64 percentage points from the prior year.
- Annual Return on Assets [ROA] has a five-year change of -38.74 percentage points (years ended Dec 2020 to Dec 2025).
- Across earlier years, Return on Assets [ROA] came in at -33.52% in the year ended Dec 31, 2024 (-29.61 pp), -3.91% in the year ended Dec 31, 2023 (+19.41 pp), -23.32% in the year ended Dec 31, 2022 (-4.94 pp) and -18.39% in the year ended Dec 31, 2021 (+1.03 pp).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Return on Assets [ROA] in data going back to the quarter ended Jun 30, 2021.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 34.76 percentage points in the quarter ended Dec 31, 2023, against a drop of 177.19 percentage points in the quarter ended Jun 30, 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Innate Pharma | 146.20 Mn | 146.20 Mn | - | -277.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -277.10% |
| Dec 31, 2025 | -180.62% |
| Jun 30, 2025 | -99.91% |
| Dec 31, 2024 | -65.56% |
| Jun 30, 2024 | -55.74% |
| Dec 31, 2023 | -33.01% |
| Jun 30, 2023 | -56.73% |
| Dec 31, 2022 | -67.77% |
| Jun 30, 2022 | -61.19% |
| Dec 31, 2021 | -56.38% |
| Jun 30, 2021 | -40.52% |
API Access
Innate Pharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();